Figure 2.

Population with bone marrow activation. Characteristics of participants with baseline bone marrow ¹⁸F-fluorodeoxyglucose uptake compared with the group without bone marrow uptake. Participants with bone marrow ¹⁸F-fluorodeoxyglucose uptake were more frequently male and had a higher prevalence of metabolic syndrome and its components, central obesity, hypertension, and altered glucose metabolism. The bone marrow uptake group also had higher levels of systemic inflammatory markers (high-sensitivity C-reactive protein and ferritin) and showed higher counts of leucocytes and red blood cells.